EntrEmed.com

About EntrEmed.com

EntreMed, Inc. (Nasdaq: ENMD) is a clinical-stage pharmaceutical company developing a new generation of multi-mechanism drugs for the treatment of cancer and inflammatory diseases. EntreMed's drug candidates target disease cells and the blood vessels that nourish them.



Retrieved from "http://aboutus.com/index.php?title=EntrEmed.com&oldid=35199514"